EXHIBIT 99.1



                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Quarterly  Report  of  Enhance  Biotech,  Inc.,  (the
"Company")  on Form 10-QSB for the quarter  ending  February 28, 2003,  as filed
with the Securities and Exchange Commission on April 2, 2003 (the "Report"),  we
certify,  pursuant to 18 U.S.C.  (S) 1350, as adopted pursuant to (S) 906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies  with the  requirements  of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.



April 28, 2003                     /s/ Buddy Young
                                  ----------------------------------------------
                                   Buddy Young, Chief Executive Officer and
                                   Chief Financial Officer